Lidocaine Hydrochloride and Dextrose - Lidocaine Hydrochloride 8 mg / mL Injection 250 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 00338-0411-02 |
|---|---|
| Product NDC | 00338-0411 |
| Generic Drug Name | Lidocaine Hydrochloride |
| Brand Name | Lidocaine Hydrochloride and Dextrose |
| Manufacturer | Baxter Healthcare Corporation |
| Strength | 8 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 24 Bag |
| Package Description | 24 BAG in 1 CARTON (0338-0411-02) / 250 mL in 1 BAG |
| Active Ingredients | Lidocaine Hydrochloride |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Lidocaine Hydrochloride 8 mg / mL Injection is tracked under NDC 00338-0411-02 and rolls up into product family 00338-0411. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 24 Bag.
- Manufacturer: Baxter Healthcare Corporation.
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
This NDC appeared in documented shortage listings more than once between 2011 and 2018, a repeat pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Lidocaine Hydrochloride in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Lidocaine Hydrochloride.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Lidocaine Hydrochloride and Dextrose - Lidocaine Hydrochloride 8 mg / mL Injection 250 mL, NDC 00338-0411-02, is a Baxter Healthcare Corporation 8 mg / mL injection presentation packaged as 24 Bag. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 00338-0411-02
- Digits-only NDC 11: 00338041102
- Possible 10-digit display formats: 0338-0411-02 (0338041102), 00338-411-02 (0033841102), 00338-0411-2 (0033804112)
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Lidocaine Hydrochloride and Dextrose
- NDC 11: 00338-0411-02
- Product family NDC: 00338-0411
- VA classification code: CV300
- VA classification code description: ANTIARRHYTHMICS
- CMOP ID: L0748
- VUID: 4005951
- UNSPSC code: 51273929
- Misc. Order Numbers: 230137